Survival Outcomes in Older Women with Oestrogen-Receptor-Positive Early-Stage Breast Cancer: Primary Endocrine Therapy vs. Surgery by Comorbidity and Frailty Levels
Cancers · 11.02.2024 · 16 (4) · 749
DOI: 10.3390/cancers16040749 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 11.02.2024. Verfasst von Yubo Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Heal…. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIHR Greater Manchester Patient Safety Research Collaboration (PSRC), University of Manchester and the China Scholarship Council.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Primary endocrine therapy (PET) offers non-surgical treatment for older women with early-stage breast cancer who are unsuitable for surgery due to frailty or comorbidity. This research assessed all-cause and breast cancer-specific mortality of PET vs. surgery in older women (≥70 years) with oestrogen-receptor-positive early-stage breast cancer by frailty and comorbidity levels. This study used UK secondary data to analyse older female patients from 2000 to 2016. Patients were censored until 31 May 2019 and grouped by the Charlson comorbidity index (CCI) and hospital frailty risk score (HFRS). Cox regression models compared all-cause and breast cancer-specific mortality between PET and surgery within each group, adjusting for patient preferences and covariates. Sensitivity analyses accounted for competing risks. There were 23,109 patients included. The hazard ratio (HR) comparing PET to surgery for overall survival decreased significantly from 2.1 (95%CI: 2.0, 2.2) to 1.2 (95%CI: 1.1, 1.5) with increasing HFRS and from 2.1 (95%CI: 2.0, 2.2) to 1.4 (95%CI 1.2, 1.7) with rising CCI. However, there was no difference in BCSM for frail older women (HR: 1.2; 0.9, 1.9). There were no differences in competing risk profiles between other causes of death and breast cancer-specific mortality with PET versus surgery, with a subdistribution hazard ratio of 1.1 (0.9, 1.4) for high-level HFRS (p = 0.261) and CCI (p = 0.093). Given limited survival gains from surgery for older patients, PET shows potential as an effective option for frail older women with early-stage breast cancer. Despite surgery outperforming PET, surgery loses its edge as frailty increases, with negligible differences in the very frail.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science C…
- Manchester Centre for Health Economics, Faculty of Biology, Medicine and Health, The University of Manchester, Oxford Road, Manchester M13 9PL, UK.
- NIHR Greater Manchester Patient Safety Research Collaboration (PSRC), The University of Manchester, Manchester M13 9PT, UK.
- Royal Derby Hospital Centre, School of Medicine, University of Nottingham, Uttoxeter Road, Derby DE22 3DT, UK.
ORCID-Profile: Yubo Wang, Douglas Steinke, Sean P Gavan, Darren M Ashcroft, Kwok-Leung Cheung
Förderung
- NIHR Greater Manchester Patient Safety Research Collaboration (PSRC)
- University of Manchester and the China Scholarship Council
Zitieren
APA
Wang, Y., Steinke, D., Gavan, S. P., Chen, T. C., Carr, M. J., Ashcroft, D. M., Cheung, K. L., & Chen, L. C. (2024). Survival Outcomes in Older Women with Oestrogen-Receptor-Positive Early-Stage Breast Cancer: Primary Endocrine Therapy vs. Surgery by Comorbidity and Frailty Levels. Cancers, 16(4), 749. https://doi.org/10.3390/cancers16040749
Vancouver
Wang Y, Steinke D, Gavan SP, Chen TC, Carr MJ, Ashcroft DM, et al. Survival Outcomes in Older Women with Oestrogen-Receptor-Positive Early-Stage Breast Cancer: Primary Endocrine Therapy vs. Surgery by Comorbidity and Frailty Levels. Cancers. 2024;16(4):749. doi:10.3390/cancers16040749
BibTeX
@article{Wang2024,
author = {Wang, Yubo and Steinke, Douglas and Gavan, Sean P and Chen, Teng-Chou and Carr, Matthew J and Ashcroft, Darren M and Cheung, Kwok-Leung and Chen, Li-Chia},
title = {Survival Outcomes in Older Women with Oestrogen-Receptor-Positive Early-Stage Breast Cancer: Primary Endocrine Therapy vs. Surgery by Comorbidity and Frailty Levels},
journal = {Cancers},
year = {2024},
volume = {16},
number = {4},
pages = {749},
doi = {10.3390/cancers16040749}
}
EUVIMED